The compound, however, did not enhance HIV-1 infection (Supplementary Figure 4D), suggesting either the viral-induced CD62L shedding is sufficient for its release or 3,4-dichloroisocouman did not affect CD62L shedding but merely reduced the degradation of soluble CD62L in treated cell culture supernatant. Here, SELL is linked to HIV-1 infection.